Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9273 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9074 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9053 |
High Similarity |
NPD7808 |
Phase 3 |
0.8994 |
High Similarity |
NPD7251 |
Discontinued |
0.8935 |
High Similarity |
NPD6797 |
Phase 2 |
0.8841 |
High Similarity |
NPD7075 |
Discontinued |
0.883 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8817 |
High Similarity |
NPD7054 |
Approved |
0.8765 |
High Similarity |
NPD7472 |
Approved |
0.8712 |
High Similarity |
NPD6801 |
Discontinued |
0.8659 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8655 |
High Similarity |
NPD7074 |
Phase 3 |
0.8634 |
High Similarity |
NPD5403 |
Approved |
0.8562 |
High Similarity |
NPD6799 |
Approved |
0.8539 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD6166 |
Phase 2 |
0.8529 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD5401 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.843 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8424 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8421 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8352 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8352 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8343 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8274 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8225 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8152 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8075 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8035 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7901 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7895 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7886 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7876 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD3749 |
Approved |
0.784 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7835 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7835 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7826 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7765 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.776 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7711 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7702 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7668 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7668 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7661 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7641 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7637 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7614 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7605 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7602 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7584 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7539 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7537 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7525 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7485 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7472 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7462 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7433 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD919 |
Approved |
0.7411 |
Intermediate Similarity |
NPD7583 |
Approved |
0.741 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7341 |
Intermediate Similarity |
NPD920 |
Approved |
0.734 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7235 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7235 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD37 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7166 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7159 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7158 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7125 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7081 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7052 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7048 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7026 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7024 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7018 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD4287 |
Approved |
0.6994 |
Remote Similarity |
NPD3225 |
Approved |
0.6994 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD1613 |
Approved |
0.6964 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6951 |
Remote Similarity |
NPD2797 |
Approved |
0.6944 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6931 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD447 |
Suspended |
0.6923 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6919 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6915 |
Remote Similarity |
NPD7680 |
Approved |
0.6914 |
Remote Similarity |
NPD7440 |
Discontinued |
0.6908 |
Remote Similarity |
NPD7930 |
Approved |
0.6901 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD7003 |
Approved |
0.6893 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD9545 |
Approved |
0.6875 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6872 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6868 |
Remote Similarity |
NPD4288 |
Approved |
0.6865 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6864 |
Remote Similarity |
NPD943 |
Approved |
0.686
|
Remote Similarity |
NPD6100 |
Approved |